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Abstract
Introduction
The infections due to Non-Tuberculosis Mycobacteria (NTM) are becoming an important
health problem in many countries in the world. Globally, an increase in NTM infections has
been reported from many countries around the world. However, limited information is avail-
able about the prevalence of NTM infections in Iran.
Material and Methods
The data of the prevalence of NTM infections were collected from databases such as
PubMed, Web of science, Cochrane Library, Embase, Scopus, Iranmedex, and Scientific
Information Database. Comprehensive Meta-Analysis (V2.0, Biostat) software was used to
analyze the data.
Results
The meta-analyses showed that the prevalence of NTM infections was 10.2% (95% confi-
dence interval [95% CI] 6.3-15.9) among culture-positive cases of tuberculosis (TB) in Iran.
The further stratified analyses indicated that the prevalence of NTM was higher in studies
that were done after year 2000. Additionally,M. simiae (43.3% [95% CI 36.8-50.0]),M. intra-
cellucar (27.3% [95% CI 0.7-95.5]) andM. fortuitum (22.7% [95% CI 16.1-30.9]) were the
most prevalent NTM species, respectively.
Discussion
The relatively high prevalence of NTM infections (10.2%) among culture positive cases for
TB underlines the need for greater enforcement of infection control strategies. Establish-
ment of appropriate diagnostic criteria and management guidelines for NTM diseases and
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expanding the number and quality of regional reference laboratories may facilitate more ac-
curate action for prevention and control of NTM infections in Iran.
Introduction
The infections due to Non-tuberculosis Mycobacteria (NTM) are an increasing problem in
many countries in the world. NTMs are environmental organisms and are commonly found in
soil, water, dust, animals and food. They are considered as opportunistic pathogens, and several
species are capable of causing serious illnesses such as pulmonary disease, skin and soft tissue
infection and disseminated infection in both immunocompetent and immunocompromised
individuals [1, 2]. Based on reports from many developed countries, the numbers of diseases
caused by NTMs are on the rise, and NTM accounts for an increasing proportion of mycobac-
terial disease [3–5]. Increase in the number of NTM associated diseases and patients may con-
tribute to the implementation of developed molecular methods for detection of NTM and the
growing population of patients susceptible to NTM infections (HIV cases). The rising number
of NTM species is of concern as these are both difficult to diagnose and treat. Unfortunately,
most of the NTM species are inherently resistant to the anti-tuberculosis (TB) agents, which
make the treatment of these infections more difficult [6]. This concern is even more serious in
economically challenged countries. In these regions, the prevalence of diseases caused by NTM
is expected to rise due to inadequate laboratory facilities. In many cases identification of myco-
bacterium to the species level is not done and NTM diseases are frequently misdiagnosed as
TB. Thus, this deferment in diagnosis of NTM can leads to development of variety of symp-
toms as well as high rate of morbidity and mortality [6]. In countries like Iran, where TB is still
a major public health problem, the prevalence of NTM diseases among TB suspects has been
rarely reported in literatures and a comprehensive analysis from different parts of Iran has not
been performed yet. In the present study, we aimed to assess the exact magnitude of NTM in-
fection and the diversity of microorganisms that found in Iranian population. Systematic re-
view and meta-analysis according to the Preferred Reporting Items for Systematic reviews and
Meta-Analyses (PRISMA) statement were used (S1 Table) [7].
Methods
Search Strategies
From January 1990 to September 2014, all studies addressing NTM infections in Iran were col-
lected from databases PubMed, Web of Science, Embase, Scopus, Cochrane Library, Google
Scholar, Iranmedex, and Scientific Information Database. The search was restricted to original
research articles that have been published in English or Persian and present the prevalence or
incidence of NTM infections in Iran. The following key words containing Medical Subject
Headings or keywords in titles or abstracts were used with the help of Boolean operators
(“and” or “or”): ‘‘non-tuberculosis”, ‘‘nontuberculosis”, ‘‘nontuberculous mycobacterium”,
“non-tuberculosis mycobacterial”, ‘‘NTM”, ‘‘mycobacteria other than tuberculosis”, ‘‘MOTT”,
‘‘atypical mycobacterium” and ‘‘Iran”. Meanwhile, bibliographies from retrieved papers were
investigated for any additional study. In addition to English papers, all relevant articles in Irani-
an databases such as Iranmedex (www.iranmedex.com), Scientific Information Database
(www.sid.ir), Magiran (www.Magiran.com), Irandoc (www.irandoc.ac.ir) and Iranian National
Library (www.nlai.ir) were searched with similar strategy and related Persian keywords.
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Inclusion and exclusion criteria
All original articles presenting cross-sectional or cohort studies on prevalence of NTM infec-
tions in Iran were considered. The selection of articles for review was done based on three
stages: titles, abstracts, and full-text evaluation. The included studies should reference to the
standard method for identification of NTM isolates. Standard methods include the convention-
al methods (i.e. niacin accumulation, growth in Lowenstein-Jensen (LJ) media containing thio-
phene-carboxylic acid hydrazide (TCH), growth at 42°C and 44°C, pigment production in light
and dark, arylsulfatase activity, catalase, tween hydrolysis, nitrate reduction, tellurite reduction,
tolerance to the NaCl 5% and urease) and molecular methods (e.g. PCR-RFLP and sequenc-
ing). In all included surveys, the effect size of the prevalence of NTM should be included in the
studies. Studies were excluded from analysis for any of the following reasons: article has fo-
cused only onMycobacterium tuberculosis; considered only specific groups such as HIV cases;
considered only NTM cases co-infected with HIV and those that have not used standard meth-
ods. Review articles, meeting or congress abstracts that have been reported in languages other
than English or Persian, meta-analyses or systematic reviews and articles available only in ab-
stract form were also excluded.
Data extraction and definitions
For all studies, the following data were extracted: the first author’s name, year of publication,
year of study, study setting, number of cases investigated, method of studies, source of samples,
sample size and prevalence of NTM infections. Two investigators extracted data from all of the
included studies independently and results were reviewed by a third investigator. Inconsisten-
cies between the reviewers were discussed to obtain consensus.
Meta-Analysis
Analysis was performed by Comprehensive Meta-Analysis (V2.0, Biostat) software. The point
estimates of effect size, the prevalence of NTM, and its 95% confidence interval (95% CI) were
estimated for each study. Random effects models were used, taking into account the possibility
of heterogeneity between studies, which was tested with the Cochran’s Q-statistic. In order to
assess possible publication bias, Egger weighted regression methods were used. Value of
P< 0.05 was considered indicative of statistically significant publication bias.
Results
Characteristics of Included Studies
Initially, a total of 254 articles were collected (Fig 1). In secondary screening, 226 of them were
excluded on the basis of the title and abstract evaluation. The exclusion of articles based on the
title of papers was mainly because of the following reasons: the articles were based on case re-
port, assessment of specific methods on NTM diagnosis, considered only specific groups of pa-
tients, reported NTM from environmental samples, reported NTM in specific disease, analysis
of specific factor in non-tuberculosis infections. In the next step 9 of the remaining 28 studies
were excluded upon a full text search; 7 have not reported NTM prevalence and 2 have used
non-standard methods. Nineteen eligible studies were chose for further investigation. Charac-
teristics of the selected articles are summarized in Table 1. Geographic location of studies cov-
ered east to west and north to south of Iran and the majority of patients were from central of
Iran. Diagnostic methods for NTMmainly included conventional techniques. Additionally,
NTM species were isolated from various clinical samples, including sputum, bronchoalveolar
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lavage (BAL), abscess, gastric washing, soft tissue infection, pleural samples, cerebrospinal fluid
(CSF) and lymph node biopsy.
The Prevalence of NTM
The heterogeneity test indicated that there were heterogeneities between studies (I2 = 96.1,
p< 0.001), so the random effect model was used to combine the prevalence of NTM. As it is
shown in Table 2, the combined prevalence of NTM infections was 10.2% (95% CI 6.3–15.9)
among culture-positive cases of TB in Iran. Fig 2 shows the forest plot of meta-analysis of
NTM prevalence. Some evidence for publication bias was observed (Fig 3), however the results
of Egger’s weighted regression test did not show bias in this study (t = 1.0, p> 0.05).
Prevalence of NTM species
As it is presented in Table 3,M. simiae (43.3% [95% CI 36.8–50.0]),M. intracellucar (27.3%
[95% CI 0.7–95.5]) andM. terrae (18.3% [95% CI 11.3–28.2]) were the most prevalent NTM
species among slowly growing mycobacteria (SGM) whileM. fortuitum (22.7% [95% CI 16.1–
30.9]),M. abcsessus (14.0% [95% CI 6.4–27.8]) andM. chelonae (7.6% [95% CI 2.8–18.8]) were
the most prevalent NTM species among rapidly growing mycobacteria (RGM).
Discussion
The current systematic review reports the prevalence of NTM infections in Iran and examines
the most prevalent NTM species among infected cases. The overall meta-analysis indicated
that the prevalence of NTM infections was 10.2% (95% CI 6.3–15.9) among culture-positive
cases of TB (Table 2). The analysis also showed that the pool prevalence of NTM infections
was higher when the time of study was after year 2000 (from 9.6% in studies before 2000 to
10.6% in studies after 2000). The reasons for the increased reports of NTM infections may be
related to: recognition of the importance of disease by physicians and microbiologists; im-
provement of laboratory facilities; and increasing the prevalence of immunocompromised
hosts that causes increase in NTM infection in the general population [8]. Overall, the relatively
Fig 1. Flow diagram of literature search and study selection.
doi:10.1371/journal.pone.0129073.g001
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high prevalence of NTM infections (10.2%) in Iran may have several negative effects on public
health. First of all, the clinical manifestations of NTM infections are frequently overlapped
with diseases caused byM. tuberculosis that makes the specific diagnosis of NTM difficult [9,
10]. Second, the increasing cases of NTM can yield false positive results in direct sputum-
Table 1. Characteristics of studies included in the meta-analysis.
Study Time of
study
Published
time
Province N. of cases with suspected
mycobacterial infections
N. of culture
positive cases
N. of NTM
isolates
Diagnostic
methods for NTM
Derakhshani
[14]
2003–2011 2014 Tehran 8322 4825 124 Conventional tests,
PCR-RFLP
Bahrmand [15] 1993–1994 1996 Tehran 6472 525 82 Conventional tests
Heidari [16] 2007–2008 2009 Tehran 371 371 43 Conventional tests,
PCR-RFLP
Mohamadi [17] 1996–1997 1998 Tehran 2272 186 30 Conventional tests
Nasiri [18] 2010–2012 2014 Tehran 6426 261 9 Conventional tests,
sequencing
Javid [19] 2007–2008 2009 Golestan - 104 17 Conventional tests
Shafipour [20] 2010–2011 2013 Golestan 3336 319 16 Conventional tests,
sequencing
Moghtaderi
[21]
2001–2010 2011 Tabriz - 235 15 Conventional tests
Heidarnejad
[22]
1999–2000 2001 Tabriz 165 165 10 Conventional tests
Rohani [23] 2007–2008 2009 Kashan 248 32 8 Conventional tests,
PCR-RFLP
Moniri [24] 1999–2000 2001 Kashan 100 100 4 Conventional tests
Nasrollahi [25] 2010–2011 2012 Mazandaran 1345 65 6 Conventional tests,
PCR-RFLP
Namaei [26] 2001–2002 2003 Mashhad 1700 98 8 Conventional tests
Yazdi [27] 2009–2010 2012 Yazd 32 32 1 Conventional tests
Roayaei [28] 1996–1997 1999 Khuzestan 6031 243 18 Conventional tests
Hashemi [29] 2009–2012 2013 Khuzestan 190 117 23 Conventional tests,
sequencing
Khosravi [30] 2007–2008 2009 Khuzestan 150 88 8 Conventional tests,
PCR-RFLP
Farivar [31] 2000–2004 2006 Sistan-
Blochestan
150 150 59 Conventional tests
Naderi [32] 2003–2004 2006 Sistan-
Blochestan
150 60 20 Conventional tests
doi:10.1371/journal.pone.0129073.t001
Table 2. Meta-analysis of prevalence of NTM infections in Iran.
Subgroups No. of
study
Prevalence of NTM
(95% CI)
n/N Heterogeneity test,
I2 (%)
Heterogeneity test, P
value
Egger’s
test, t
Egger’s test, P
value
Overall effects 19 10.2 (6.3–15.9) 501/
7976
96.1 <.001 1.0 0.33
Research before
year 2000
5 9.6 (6.0–15.0) 144/
1219
83.4 <.001 3.2 0.04
Research after year
2000
14 10.6 (5.6–19.2) 357/
6757
96.8 <.001 1.5 0.15
Abbreviations: n, number of events (NTM isolates); N, total number of culture positive cases.
doi:10.1371/journal.pone.0129073.t002
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smear microscopy of acid-fast bacilli (AFB) which can pose a challenge for a directly observed
treatment–short course (DOTS) program. Under the DOTS strategy, treatment of TB is started
only on the basis of sputum microscopy results [9]. Therefore, a false-positive AFB can put
NTM infected individuals on anti-TB chemotherapy, even though the treatment of NTM dis-
ease is not similar to treatment of TB [6, 9]. Third, the most NTM infections typically occur
only during severe immune suppression when the T lymphocyte number falls below the base-
line level. Therefore, HIV/AIDS patients are significantly more vulnerable to NTM infections
due to their suppressed immune system. It is important in studied country where it is estimated
that more than 20 thousands of people are infected with HIV virus [11]. Moreover, the stan-
dardized or accepted criteria to define NTM disease are missing in Iran that makes the diagno-
sis more difficult.
Another important finding of this study was the high prevalence of RGM such asM. fortui-
tum,M. abcsessus andM. chelonae (Table 3). These species are the most common NTM isolates
associated with nosocomial disease [12]. Previous studies demonstrated that tap water, ice pre-
pared from tap water, processed tap water used for dialysis, and piped water systems in hospital
Fig 2. Forest plot of the meta-analysis on prevalence of NTM infections.
doi:10.1371/journal.pone.0129073.g002
Fig 3. Funnel plot of the meta-analysis on prevalence of NTM infections.
doi:10.1371/journal.pone.0129073.g003
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settings are the usual nosocomial sources of NTM infections [12]. Compare toM. tuberculosis,
NTMs are even more difficult to eradicate with common decontamination practices and are
relatively resistant to standard disinfectants such as chlorine and alkaline glutaraldehydes [13].
Furthermore, each NTM species may have its own antibiotic susceptibility pattern and they are
usually more resistance to antimicrobial agents compared toM. tuberculosis and SGM [6]. In
this regards, transmission and spread of these NTM species from nosocomial sources may con-
stitute the major part of the problem in hospital control strategies.
Some limitations of this review should be discussed. First of all, only published studies were
included in the current meta-analysis. Thus, as with any systematic review, existence of poten-
tial publication bias should be considered. Second, heterogeneity was detected among the in-
cluded studies. Third, it cannot fully represent the prevalence of NTM infections in Iran
because the extent of NTM infections is not yet examined in many areas of the country. In
Table 3. Meta-analysis of species distribution among infected cases.
Classification NTM species No. of
study
Prevalence of
NTM (95% CI)
n/N Heterogeneity
test, I2 (%)
Heterogeneity
test, P value
Egger’s
test, t
Egger’s
test, P
value
Slowly growing
mycobacteria (SGM)
M. Kansassi 7 13.1 (9.7–17.4) 40/
316
0.0 0.70 0.6 0.54
M. simiae 5 43.3 (36.8–50.0) 93/
215
0.0 0.80 0.7 0.53
M. gordonae 4 9.8 (3.6–24.2) 6/82 34.0 0.20 1.7 0.21
M. avium complex 3 18.0 (6.7–40.5) 9/53 52.0 0.13 2.9 0.20
M. scrofulaceum 3 6.1 (3.1–11.8) 8/
143
0.0 0.43 1.4 0.39
M. szulgai 3 8.6 (2.4–26.8) 7/
115
65.8 0.05 0.6 0.63
M. gastri 2 16.5 (5.0–42.7) 20/
98
50.1 0.15 - -
M. flavescens 2 2.7 (0.5–12.8) 2/98 26.8 0.24 - -
M. intracellucar 2 27.3 (0.7–95.5) 8/51 92.9 0.00 - -
M.
nonchromogenicum
1 6.3 (0.9–33.5) 1/16 - - - -
M. terrae 1 18.3 (11.3–28.2) 15/
82
- - - -
M. lentiflavum 1 6.3 (0.9–33.5) 1/16 - - - -
M. triviale 1 5.6 (0.8–30.7) 1/18 - - - -
M. asiaticum 1 3.7 (1.2–10.7) 3/82 - - - -
M. malmoense 1 4.7 (1.2–16.8) 2/43 - - - -
M. xenopi 1 5.6 (0.8–30.7) 1/18 - - - -
Rapidly growing
mycobacteria (RGM)
M. fortuitum 6 22.7 (16.1–30.9) 43/
197
22.3 0.26 1.1 0.30
M. chelonae 4 7.6 (2.8–18.8) 27/
265
69.4 0.02 2.5 0.12
M. fallax 1 1.2 (0.2–8.1) 1/82 - - - -
M. thermoresistibile 1 1.2 (0.2–8.1) 1/82 - - - -
M. smegmatis 1 5.6 (0.8–30.7) 1/18 - - - -
M. phlei 1 4.9 (1.8–12.3) 4/82 - - - -
M. abcsessus 1 14.0 (6.4–27.8) 6/43 - - - -
Abbreviations: n, number of events (NTM isolates); N, total number of culture positive cases.
doi:10.1371/journal.pone.0129073.t003
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conclusion, the increase in the number of NTM infections is a serious public health problem in
Iran and merit further attention by health authorities, physicians, and microbiologists. Estab-
lishment of appropriate diagnostic criteria and management guidelines for NTM diseases and
expanding the number and quality of regional reference laboratories may facilitate more accu-
rate action for prevention and control of NTM infections in Iran. The recognition of NTM as
an ‘emerging pathogens’ would perhaps elevate the status of NTM in infections
control strategies.
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